Uroalerts Men's Health Weekly

September 08, 2025

Videos

Peer-to-Peer Clinical Conversations

Comparing Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia - Dean Elterman

Dean Elterman

Alan Wein is joined by Dean Elterman to discuss BPH procedure selection based on patient characteristics and preferences.

Analysis of Treatment Options for Male Stress Urinary Incontinence - Craig Comiter

Craig Comiter

In part three, Alan Wein continues his discussion with Craig Comiter about male incontinence treatments, covering ProACT periurethral balloons, stem cell therapy, and treatment selection.

Beyond the Abstracts

History of Vasectomy Is Not Associated with Prostate Cancer Progression in Men on Active Surveillance - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

Integrated subcellular localization of functional fluorescence probes and functional analysis in motile spermatozoa by an AI-enhanced algorithm.

Redo testicular sperm aspiration (TESA) in men with severe oligoasthenoteratozoospermia (OAT) and obstructive azoospermia (OA).

Testicular germ cell tumors and infertility: Exploring epigenetic dysregulation in the journey of the male germ cell towards new biomarkers and therapeutics.

Peyronie's Disease

A cost-effective modified split graft technique using bovine pericardium after plaque excision in Peyronie's disease - An initial experience.

Prostatitis

S100A12 correlates with inflammatory and pain symptoms in patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Erectile Dysfunction

Oral drug treatments of erectile dysfunction: a AFU/SFMS systematic review.

Ligation and embolization in one procedure for caverno-venous leakage in 171 patients with drug-resistant erectile dysfunction.

BPH - Benign Prostatic Enlargement

Impact of metabolic syndrome on combination therapy efficacy in LUTS due to BPH: a prospective study.

Step-by-step anatomical photovaporization of the prostate using 180-W XPS greenlight laser: optimizing functional outcomes through energy modulation.

Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial.

Aquablation versus HoLEP: Propensity score matching analysis of functional outcomes and ejaculation preservation.

Penile & Urethral Cancers

Interplay of PD-L1, FOXP3, and CD8 in the Immune Microenvironment of Penile Squamous Cell Carcinoma: Expression Profiles and Correlations.

Human papillomavirus vaccination and its effect on genital men's health. Considerations for a public health strategy.

Oncological outcomes and organ preservation after brachytherapy for penile carcinoma: A multicentric retrospective study by the Brachytherapy Group of the French Society for Radiation Oncology.

Single-Port Antegrade Robotic Lymphadenectomy: A Novel Minimally Invasive Approach to Treat Lymph Nodes in Men with Penile Cancer - Beyond the Abstract

Testicular Cancer

Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors.

Exposure to per- and polyfluoroalkyl substances during fetal development and risk of testicular germ cell cancer in adulthood.

Prostate Cancer

Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis.

A Payment Incentive to Improve Confirmatory Testing in Men With Prostate Cancer.

Effect of bone marrow disease on hematologic toxicity and response to [177Lu]Lu-PSMA-617 therapy: insights from PSMA-PET/CT imaging.

The Blind Spot of PSMA-PET Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer.

Simple prostatectomy followed by radiation therapy for prostate cancer: a novel treatment pathway for men with marked prostatomegaly and prostate cancer: a series of cases.

Clinical Comparison of Decipher 1.0 and 1.1 for Localized Prostate Cancer: Results in Prostatectomy and Active Surveillance Patients.

Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial.

Renal, bladder and prostate cancer surgery outcomes with respect to team familiarity.

Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With Apalutamide.

A sensitive and specific non-invasive urine biomarker panel for prostate cancer detection.

Treatment Landscape for Older Men With Metastatic Hormone-Sensitive Prostate Cancer in the United States.

Low-Dose Abiraterone in Metastatic Castration-Resistant Prostate Cancer.

Depend® Teams Up with Ken Griffey Jr. & Sr. to Inspire Early Detection and Open Conversation Around Prostate Cancer

Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study.

Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.

Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome.

Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model.

Examining the association between real-world extended vs. standard pelvic lymph node dissection and early and late oncologic outcomes in men undergoing radical prostatectomy.

Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.

Factors Associated with Recovery of Urinary Continence: A Multicenter Comparison of Pelvic Fascia-sparing and Standard Robotic-assisted Radical Prostatectomy - Beyond the Abstract

Single- versus multi-model in the deep learning prediction of monitor units per control point for automated treatment planning in prostate cancer.

Cost-effectiveness of talazoparib plus enzalutamide as first-line therapy in metastatic castration-resistant prostate cancer.

Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy.

Comparative Performance of the CamPROBE Local Anaesthetic Transperineal Biopsy Device Versus an In-Line Device for Detection of Significant Prostate Cancer.

Reassessing the Evidence: Is Intensified Therapy Justified in Older Patients with Metastatic Hormone-Sensitive Prostate Cancer?

Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy.

Reduced recurrence of prostate cancer with novel autologous cancer vaccine (FK- PC101) post-prostatectomy: long-term results from a single-center phase 1/2 study.

Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of 177Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol.

Rectal spacer use and overall long-term healthcare costs: payer perspective.

AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysis.

Neurovascular bundle preservation improves postoperative continence recovery in robotic-assisted laparoscopic radical prostatectomy after neoadjuvant hormonal therapy in the treatment of locally advanced prostate cancer: results from a propensity score-ma

The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis.

HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.

CHD1 Loss Reprograms SREBP2-Driven Cholesterol Synthesis to Fuel Androgen-Responsive Growth and Castration Resistance in SPOP-Mutated Prostate Tumors - Beyond the Abstract

Rectal Spacer Use and Bowel, Urinary, and Sexual Dysfunction Diagnosis and Related Procedures Among Men Receiving Prostate Radiotherapy: US County-Level Analysis - Beyond the Abstract

Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data - Beyond the Abstract

Integrating Genomic Classifiers and Nonsuspicious Magnetic Resonance Imaging Findings in Predictive Modelling for Lymph Node Metastasis in Patients with Localized Prostate Cancer - Beyond the Abstract

Postdiagnosis Physical Activity Is Associated with Improved Survival in Prostate Cancer Patients Treated with Surgery but Not with Radiation Therapy - Beyond the Abstract

Development of an in Situ CAR-T Cell Protocol Through Optical and PSMA-Targeted PET Imaging - Beyond the Abstract

Acute Toxicity of SBRT in Localized Prostate Cancer: A Spanish Multicenter Study - Beyond the Abstract

The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era - Beyond the Abstract

Engaging for Equity: Lessons from a Cross-Sector Partnership Addressing Prostate Cancer Risk in the Black Community - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC